Projected NPAT of $12.5m, up from $12.1 last year. 3% growth in NPAT is not fantastic, but they are investing to grow the business, so will be interested to see the reports.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
